Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

5 months ago 208

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.

Read Entire Article

Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

Related

Teradyne’s stock soars after this ‘absolute blowout’ forecas...

AMD’s stock rises ahead of earnings. Why investors are feeli...

SpaceX officially acquires xAI. Here’s how Elon Musk justifi...

Trending

Popular

Bitcoin tests key support as bulls reset to prepare for futu...

Nasdaq and CME Group join forces to launch Nasdaq-CME Crypto...

Anti-DeFi group runs ads urging public to pressure Senators ...

Crypto Fear and Greed Index flips to 'neutral' for first tim...

9 myths about Bitcoin energy use, debunked by data: ESG expe...

CFTC issues no-action letter to Bitnomial, clearing way for ...

Pump.fun says creator fees ‘may have skewed’ incentives, pla...

Starknet publishes post-mortem report after temporary networ...

Solana Mobile sets Jan. 21 launch date for SKR token, confir...

Trump takedown of Venezuela’s dictator could inject price pr...